Anxiety screening
Pro Research Analysisby 
Searched over 200M research papers for "anxiety screening"
Anxiety Screening: Insights from Recent Research
Importance of Anxiety Screening in Primary Care
Anxiety disorders are prevalent yet often underdiagnosed in routine healthcare settings, particularly among adolescent girls and adult women. Effective screening can lead to early diagnosis and treatment, improving overall health outcomes1 4. The Women's Preventive Services Initiative (WPSI) recommends screening for anxiety in women and adolescent girls aged 13 years or older, including pregnant and postpartum women, to enhance detection and treatment4.
Accuracy of Screening Instruments
Generalized Anxiety Disorder Scale (GAD-7)
The GAD-7 is a widely used tool for screening generalized anxiety disorder. Studies have shown it to have moderate to high accuracy, with sensitivity ranging from 70% to 97% and specificity from 50% to 89% in adults1. In low- to middle-income countries (LMICs), the GAD-7 has also been validated, showing a pooled sensitivity of 76% and specificity of 64%5.
Screen for Child Anxiety Related Emotional Disorders (SCARED)
The SCARED instrument is commonly used to evaluate anxiety symptoms in children and adolescents. It has demonstrated excellent internal consistency and moderate to large test-retest reliabilities. The parent and child versions of SCARED have shown robust psychometric properties across various countries, making it a reliable tool for screening childhood anxiety disorders3 6 9.
Edinburgh Postnatal Depression Scale (EPDS)
For pregnant and postpartum women, the EPDS has been adapted to screen for anxiety, showing a sensitivity of 74% and specificity of 64%1. This tool helps in identifying anxiety symptoms during a critical period, ensuring timely intervention.
Effectiveness of Treatments for Screen-Detected Anxiety
Cognitive Behavioral Therapy (CBT)
CBT has been found to be effective in improving anxiety symptoms across various populations. A systematic review of 246 randomized controlled trials (RCTs) involving 17,209 participants confirmed the efficacy of CBT in reducing anxiety symptoms1 4. In pediatric primary care, individual CBT has also been effective for adolescents with social phobia identified through screening2.
Pharmacologic Treatments
Antianxiety medications, including selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs), have been shown to improve anxiety symptoms. A review of 126 RCTs involving 8,225 participants supported the effectiveness of these medications in treating anxiety disorders1 4.
Limitations and Gaps in Current Research
Despite the availability of effective screening tools and treatments, there are significant gaps in the evidence related to the overall effectiveness and harms of anxiety screening in primary care settings. No studies have directly evaluated the long-term harms of treatment, and there is a lack of treatment trials specifically for pregnant or postpartum women1 4. Additionally, many screening tools have been validated in inadequately designed studies, particularly in LMICs, limiting their generalizability5.
Conclusion
Screening for anxiety in primary care settings is crucial for early detection and treatment, particularly among high-risk groups such as adolescent girls, adult women, and children. While tools like the GAD-7 and SCARED have shown high accuracy and reliability, more research is needed to evaluate the long-term benefits and potential harms of screening. Effective treatments, including CBT and pharmacologic options, are available and can significantly improve anxiety symptoms when identified early.
Sources and full results
Most relevant research papers on this topic